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We have  investigated  the time-dependent  effect  of multi-walled  carbon  nanotubes  (MWC-
NTs) in rats  upon  single  inhalation  exposure  followed  by  intermittent  sacriﬁce.  The  effects
were  monitored  by  analyzing  the  bronchoalveolar  lavage  ﬂuid  (BALF)  and  histopatho-
logical  analysis.  Cell  count,  neutrophils,  lymphocytes,  lactate  dehydrogenase,  alkaline
phosphatase,  protein  and  cytokines  (tumor  necrosis  factor-alpha  (TNF-)  and  interleukin
4  (IL-4))  were  signiﬁcantly  increased,  while  cell  viability  and  alveolar  macrophage  count
signiﬁcantly  decreased  in  the  BALF  of  MWCNT-treated  rats  on  day 1,  day  7 and  day  14
post-exposure,  when  compared  to control  rats.  Histopathological  analysis  revealed  inﬂam-
mation, ﬁbrosis  and  granuloma  in  the lungs  of  MWCNTs-treated  rats  on  day 7 and  day
14 post-exposure.  We  interpret  that MWCNT  induces  inﬂammation,  ﬁbrosis  and granu-ytokines
ntermittent
loma  characterized  by progressive  elevation  of  TNF-  and  IL-4. Histopathological  studies
further support  our view  and  reveal  the  distribution  of  MWCNT  in lungs  and  tracheo-
bronchial  lymph  nodes  (TBLN).  We  conclude  that MWCNT-induced  pulmonary  toxicity  is
considerable  even  on single  exposure.
s.  Publ
Y-NC-N©  2015  The  Author
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. Introduction
Carbon nanotubes (CNTs) due to their unique properties
re making a breakthrough in industries and biomedicine
1]. As a result, the production rate of CNTs is rising consid-
rably. Recent reports reveal that the global production of
NTs exceeds several thousand tons per year [2]. In this sce-
ario, the exposure of the environment including human
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beings and the ecosystem to CNTs and the threat of CNT tox-
icity are also increasing. However, the information about
the possible human health and environmental impacts pro-
duced by CNTs is still scanty. CNTs exhibit a toxic potential,
similar to those observed with ﬁbrous materials due to
their high aspect ratio [3]. CNTs induced dose-dependent
severity of the lesions like persistent epitheloid granu-
lomas and interstitial inﬂammation in mice after single
intra-tracheal treatment was  observed [4]. In mice and rats,
pulmonary inﬂammation characterized by alterations in
cellularity and enzyme activities of bronchoalveolar lavage
ﬂuid (BALF) and microscopic ﬁndings like inﬁltration
of macrophage, granulomas, and ﬁbrosis were observed
after intra-tracheal administration of SWCNTs or MWCNTs
[5–7]. Long MWCNTs with needle shaped structure, similar
cess article under the CC BY-NC-ND license (http://creativecommons.org/
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to asbestos, produce asbestos-like pathological changes
after intraperitoneal injection [8]. Moreover, histopatho-
logical lesions were observed in the in the upper and
lower parts of respiratory tract after inhalation exposure
of rats to MWCNTs. Previous studies reported the inﬂam-
matory changes by examining the BALF, which revealed the
variation in polymorphonuclear neutrophils, macrophages,
lymphocytes and expression of inﬂammatory cytokines
[9,10]. However, the time dependent studies on effects of
CNTs in lung after one time nose-only inhalation and the
mechanism of toxicity are limited.
We investigated the time dependent pulmonary tox-
icity of MWCNTs after one time nose-only inhalation of
MWCNTs followed by intermittent sacriﬁce on day 1, 7
and 14 post-exposure in rat model. The concentrations
of MWCNTs were selected based on permissible exposure
limit of carbon materials such as graphite as reported by
National Institute for Occupational Safety and Health, USA
[34]. The inﬂammatory and ﬁbrotic responses in the lung
of MWCNTs-inhaled rats were examined by the changes
in the lung histopathology, alveolar macrophages, neu-
trophils, lymphocytes and the expression of TNF- and IL-4
in the broncho-alveolar lavage ﬂuid.
2. Experimental details
2.1. Materials
MWCNTs (purity > 95%), obtained as gift sample from
Department of Physics, IIT, Madras, were used for the cur-
rent study. Cytokine kits (Tumor Necrosis Factor-alpha
(TNF-)  and Interleukin-4 (IL-4)) were purchased from Ray
Biotech USA. All other chemicals and reagents used for
the study were procured from Sigma–Aldrich Corporation,
India.
2.2. Animals
Twenty-four male Wistar rats with body weight
180–200 g, free from clinical signs of disease, were
obtained from the Animal house, International Institute of
Biotechnology and Toxicology (IIBAT), Padappai, India. The
protocol of animal study was approved by Institutional Ani-
mal  Ethics Committee (6/106/IAEC/2013). The rats were
divided into four groups and housed in polypropylene
cages in a room on a 12:12-h light/dark photoperiod at a
temperature of 23 ± 2 ◦C and relative humidity of 53 ± 5%.
Rats were provided with gamma-irradiated rodent pel-
let feed (Tetragon Chemie Pvt. Ltd., Bangalore, India) and
reverse osmosis water ad libitum except during the expo-
sure period. Animals were permitted to acclimatize to the
animal room conditions for one week before the initiation
of the study. All animals were acclimatized for 6 h to the
inhalation system on 2 consecutive days before start of
the exposure period and the experimental conditions were
similar to those used in pilot study.2.3. Characterization of MWCNTs
The structural alignment of MWCNTs and purity
were determined from X-ray diffraction analysis usingports 2 (2015) 111–120
Rigaku diffract meter with Cu-K radiation  = 1.54060 A˚.
The diffraction pattern was obtained in the range of
2 = 20–80◦. The obtained diffraction pattern was com-
pared with standard JCPDS values to determine their
crystal system and its related parameter. Moreover, the
surface morphology of MWCNTs was determined using
high-resolution scanning electron microscope HRSEM (FEI
Quanta FEG 200, Japan) and FEI Tencai 30 G2 S-TWIN high-
resolution transmission electron microscopy (HRTEM). The
elemental analysis (EDAX) was done by RTEM2 EDAX,
AMETEK operating at 250 kV.
2.4. MWCNTs exposure
Male Wistar rats were exposed to MWCNTs using
nose-only inhalation exposure chambers (CH. Technolo-
gies, USA) for 4 h, to an aerosol concentration of 5 mg/m3.
The concentrations of MWCNTs were selected based on
permissible exposure limit of carbon materials such as
graphite as reported by National Institute for Occupational
Safety and Health (NIOSH) [34]. The inhalation systems
contain three major modules: an aerosol generator –
Wright Dust Feeder (BGI, Inc.), a rodent nose-only inhala-
tion exposure chamber and an aerosol concentration
measurement device – gravimetric single ﬁlter (BGI, Inc.).
The rats were kept in glass restraint tubes (attached to
the wall of the cylinder) with their snouts projecting into
the inhalation chamber. The dilution of the aerosol in the
breathing zone with external air was avoided by generating
positive pressure inside the inhalation chamber. Moreover,
the whole exposure system was  kept under exhaust hoods
in an air-conditioned room. MWCNTs aerosols were gener-
ated using the Wright Dust feeder, which was  connected to
the inlets of each inhalation chamber. The actual concen-
trations of the MWCNTs in the inhalation chambers were
determined gravimetrically 3 times during each exposure
day. In addition, samples were taken twice from the expo-
sure chambers to determine the mass median aerodynamic
diameter (MMAD) and geometric standard deviation (GSD)
using a Mercer seven-stage cascade impactor (CH Tech-
nologies, USA). A pilot study was  performed in advance
to the animal exposure by generating MWCNT aerosols
continuously for 4 h in inhalation chamber to realize the
particle size distribution of the generated aerosol.
To explore the exacerbation of toxic effects of MWCNTs
exposure due to the biopersistance of nanotubes, the rats
were sacriﬁced on day 1, day 7 and day 14 post-exposure.
The toxicity potential was  determined by observing body
weight, food consumption parameters, and the clinical
signs of toxicity throughout the study.
2.5. Broncho-alveolar lavage ﬂuid analysis
Rats were euthanized with an overdose of Thiopen-
tone I.P. (ThiosolTM sodium) via intraperitoneal injection.
The right portion of the lungs of rats was immediately
lavaged twice with 5 mL  of Ca2+, Mg2+ free phosphate
buffered saline (Himedia, India). About 90% of the total
volume instilled was  retrieved and the volume is simi-
lar in all groups. The lavage collections were centrifuged
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t 400 × g for 10 min  at 4 ◦C. The cell pellet obtained
as re-suspended in RPMI 1640 (Himedia, India) and
sed for the estimation of cell viability as well as total
nd differential cell counts. Cell viability was determined
sing trypan blue dye and the total cells were counted
n an Automatic Cell Counter (CountessTM automated cell
ounter, Invitrogen). Differential cell counts were done
sing the slides prepared by cytocentrifuge, which was
xed using methanol and stained with Geimsa stain. A
otal of 500 cells per slide were counted randomly from
0 different sites under an oil-immersion microscope
ith 1000× magniﬁcation for alveolar macrophages, neu-
rophils and lymphocytes, which were identiﬁed by their
haracteristic cell morphology. The biochemical parame-
ers (lactate dehydrogenase (LDH), alkaline phosphatase
ALP) and total protein (TP)) and cytokines analysis were
erformed using the supernatant. Biochemical assays were
one spectrophotometrically using a Dimension Xpand
lus (Siemens, USA) clinical chemistry analyser.
.6. Cytokine estimation
Pro-inﬂammatory cytokine, i.e., tumor necrosis factor-
lpha (TNF-)  (Ray Biotech, USA) and pro-ﬁbrotic cytokine
.e., interleukin-4 (IL-4), levels were quantiﬁed in bron-
hoalveolar lavage ﬂuid (BALF) using ELISA kits according
o the manufacturer’s instructions. The amount of cytokine
as estimated using the standard curve obtained from
ytokine standards included in the kits.
.7. Histopathology
The left portion of the lung along with the tracheo-
ronchial lymph nodes from all animals was collected
nd preserved in 10% neutral-buffered formalin. The lungs
ere inﬂated with 10% neutral-buffered formalin before
reservation. The organs were processed in a vacuum inﬁl-
ration tissue processor (Sakura Tissue-Tek® VIPTM, Japan),
mbedded (Sakura Tissue-Tele TECTM, Japan) in parafﬁn
ax, sectioned (Microm GmbH, Germany) at approxi-
ately 5 m thick, stained (Leica ST5020-Autostainer,
Fig. 1. X-ray diffraction paports 2 (2015) 111–120 113
Germany) with hematoxylin and eosin, viewed under light
microscope (Nikon50i, Japan), and the images were cap-
tured through an image analyser (Q-Imaging systems,
Canada). The identity and analysis of the pathology slides
were blind to the pathologist.
2.8. Statistical analysis
Statistical analyses were conducted with SAS 9.3 soft-
ware. Data were expressed as mean ± SD (n = 6). Data from
different time points were compared using a one-way anal-
ysis of variance followed by Student–Newman–Keuls Test.
A criterion for statistical signiﬁcance for all tests was set
at P < 0.05 and levels of signiﬁcance were represented for
each result.
3. Results and discussion
The size and the morphology of MWCNTs were deter-
mined using HRSEM and HRTEM while the composition
and the purity were determined using EDAX and XRD.
The X-ray diffraction pattern of the MWCNTs is shown in
Fig. 1. The diffraction peak in the XRD pattern of MWCNTs
clearly conﬁrms the removal of catalytic impurities. The
lower alignment of MWCNTs was  explained by the strong
(0 0 2) peak in the XRD pattern. The HRSEM and HRTEM
images of MWCNTs are shown in Fig. 2. The surface mor-
phology of MWCNTs is clearly revealed in both the images
(size scale 100 nm). The diameter of MWCNTs was found
to be 15–50 nm.  The micrographs also clearly indicate the
dimensions and packing density of MWCNTs showing the
partial alignment of MWCNTs. The EDAX result showed a
major peak of carbon that conﬁrmed the purity as shown
in Fig. 3.
We determined the magnitude of inhalation toxicity of
MWCNTs by intermittent sacriﬁce at days 1, 7 and 14 post-
exposure in male Wistar rats. BALF parameters and lung
histopathology were used as toxicity indices.
The animals were exposed to MWCNTs followed by a
pilot study, which explains the particle size distribution of
the generated aerosol. The particle size distribution is an
ttern of MWCNTs.
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s showiFig. 2. (A) HRSEM and (B) HRTEM image
essential parameter that explains tendency of the deposi-
tion of nanomaterials in lung. A previous study reported by
Ryman-Rasmussen et al. [11], Myojo et al. [12] and Ger-
aets et al. [13] reveals the size dependent deposition of
particles in the respiratory tract. The rats were exposed
to MWCNTs for of 4 h continuously at an average actual
aerosol concentration of 5 mg/m3, while the control rats
were exposed to clean air. The distribution of aerosol parti-
cles was assessed periodically and found to have an average
MMAD  of 1.82 m and average GSD of 2.54 m.  The tem-
perature and relative humidity at the breathing zone were
determined at proper interval of time and found to be
21–22.30 ◦C and 50–55% respectively. Oxygen concentra-
tion was above 21% all through the experiment. All these
parameters conﬁrm that the aerosols were not static.
Fig. 3. EDAX proﬁle with domng the surface morphology of MWCNTs.
3.1. Cytological and biochemical analysis of BALF
Cell count and the cell viability of the BALF sample are
shown in Fig. 4. Single inhalation exposure of MWCNTs
resulted in a signiﬁcant increase in the cell count in day 1
when compared to control. The cell count attained a peak
at day 7 and was  signiﬁcantly higher than the control and
the day 1 sample. This increase could be due to (i) recruit-
ment of macrophages, neutrophils and lymphocytes upon
inﬂammation and (ii) rupture of alveolar epithelium results
in the release of epithelial cells induced by MWCNTs [9].
A slight decrease in cell count (but not signiﬁcant) was
observed in day 14 compared to the rats sacriﬁced at day
7 which may  due to the fall in the free MWCNTs in the
alveolar space owing to phagocytosis.
inant peaks of Carbon.
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Fig. 4. Changes in the (A) total cell count (quantiﬁed using cell counter) and (B) cell viability in BALF collected from the rats exposed to MWCNTs for 4 h
and  sacriﬁced intermittently on different days (days 1, 7 and 14) after inhalation. Values are expressed in mean ± S.D.; (n = 6 animals/group). *Values are
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A signiﬁcant decrease in the viability of BALF cells was
bserved at all the three time points compared with that of
ontrol rats (Fig. 4). The fall in cell viability was results from
i) Cellular oxidative stress in the lungs and (ii) Mechanical
amage in the alveolar epithelium induced by MWCNTs.
oreover the nanoparticles with ﬁbrous and oblong mor-
hology such as CNTs could be produce macrophage cell
amage during their engulfment. This may  also result in
oss of cell viability The current ﬁndings were coincides
ith the previous studies reported by Ma-Hock et al. [9]
nd Srinivas et al. [14] on nanomaterials suggested that
he signiﬁcant increase in the total cell count and decrease
n the cell viability of BALF was an indicator of pulmonary
oxicity.
The respective percentage of BALF alveolar
acrophages, neutrophil and lymphocyte counts are
hown in Fig. 5. The presence of neutrophils and lympho-
ytes in BALF collected from animals sacriﬁced on 7th and
4th day after exposure is shown in Fig. 5B and C. The
eutrophil count in BALF was found to be increased and
eached a maximum of about 26% at day 7 post-exposure.
s neutrophils are the characteristic indicators of initial
tage of inﬂammation [15–17], we infer that inﬂamma-
ion is maximally reﬂected after a week of exposure to
WCNTs. The lymphocytes were marginally increased
hroughout the observation period with a peak at day 14
ost-exposure. As lymphocyte elevation in the BALF is an
ndex of chronic inﬂammatory response, we suggest that
WCNTs induces chronic inﬂammation. We  hypothesize
hat the chronic inﬂammation may  be due to biopersis-
ence of MWCNTs in the lungs. This hypothesis is further
upported by the histopathology of the lungs of the rats
acriﬁced on day 14 post-exposure (Fig. 9). The percentage
f alveolar macrophages was found to be decreased in
ccordance with the relative increase of neutrophils
nd lymphocytes throughout the observation period
Fig. 5A).Morphologically, MWCNT laden alveolar macrophages
ere noticed in rats sacriﬁced at day 1, day 7 and day
4 post-exposure. Binucleated and multinucleated alve-
lar macrophages of variable size possessing numerous different from MWCNTs exposed rats sacriﬁced on day 1 post-exposure
cytoplasmic vacuoles were observed in the BALF of ani-
mals sacriﬁced on 7th and 14th day post-exposure (Fig. 6).
Umeda et al. [18] reported that the presence of bi- and
multi-nucleated macrophages was  mainly due to the
mitotic inhibition of alveolar macrophages with phago-
cytosed MWCNTs. We suggest that MWCNTs might have
bound to the mitotic spindle thus preventing further divi-
sion of macrophages.
Altered LDH and ALP activities together with total
protein content in the lavage ﬂuid are the markers of pul-
monary disorders. We  observed a signiﬁcant and gradual
increase in LDH, TP and ALP values increased gradually from
day 1 to day 7 post-exposure (Fig. 7). However, on day 14
a slight decrease in all the parameters was observed when
compared to day 7 after exposure. This may  be due to a fall
in the concentration of free MWCNTs in alveolar space.
MWCNTs induced cytotoxicity in the lung is con-
ﬁrmed by the signiﬁcant leakage of protein and LDH from
pulmonary epithelium. LDH concentration in BALF is mea-
surable only in the presence of cell injury, while protein
level in BALF was used as a marker to determine the
integrity of the alveolar epithelial-capillary barrier. Our
ﬁndings are in line with previous studies, which conﬁrms
the presence of LDH in BALF as an indication of the pul-
monary damage [19–22]. The higher concentration of ALP
point out the involvement of type II cells, which plays a
major role in the repair of alveolar epithelium after injury.
Previous reports also conﬁrmed the increase of ALP activity
(a marker of type II cell damage or proliferation) in BALF on
exposure to pneumotoxicants [9,23–25].
3.2. Cytokine analysis of BALF
Fig. 8A and B shows the level of TNF- and IL4 in the con-
trol and MWCNT-exposed rats. TNF- content in the BALF
of MWCNTs-exposed rats was signiﬁcantly (P < 0.05) higher
in day 1, day 7 and day 14 post-exposure. The degree of
increase correlated directly with the days of post-exposure.
The role of pro-inﬂammatory cytokines in the initiation and
progression of inﬂammatory reaction was  reported in vari-
ous studies [26–29]. The increase in TNF- in our study may
116 A.P. Francis et al. / Toxicology Reports 2 (2015) 111–120
Fig. 5. Percentage of (A) alveolar macrophages, (B) neutrophils and (C) lymphocytes in BALF collected from the rats exposed to MWCNT for 4 h and sacriﬁced
intermittently on day 1, 7 and 14 post-exposure. Values are expressed in mean ± S.D. (n = 6 animals/group). *Values are statistically signiﬁcant from the
control group (P < 0.05). #Values are signiﬁcantly different from MWCNTs exposed rats sacriﬁced on day 1 post-exposure (P < 0.05).
Fig. 6. Cytology of BALF on: (A) day 1 post-exposure, the cellularity of BALF was predominated with alveolar macrophages. Arrow indicates the MWCNT
laden  alveolar macrophages. (B) Day 7 post-exposure, the neutrophils were increased comparatively. (C) Day 14 post-exposure, tendency to increase in
number  of lymphocytes in BALF was observed. Giemsa ×400.
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ntermittently on different days (days 1, 7 and 14) after inhalation. Valu
igniﬁcant from the control group (P < 0.05).
e due to increase in inﬂammation and due to phagocytosis
f MWCNT by macrophages.
IL-4 concentration in BALF of rats treated with MWCNTs
id not show any differences on day 1 post-exposure com-
ared to control groups. However level was signiﬁcantly
ncreased on day 7 and day 14 when compared to con-
rol rats. IL-4 is a proﬁbrogenic cytokine [30]. Huaux et al.
31] have reported IL-4 as a reliable indicator of ﬁbrosis
n mice treated with bleomycin. Dose dependent ﬁbrotic
otential of intra tracheally instilled MWCNT in lung was
reviously reported by Muller et al. [32], by using an alter-
ative ﬁbrogenic index hydroxyl proline index. Correlating
hese reports with our ﬁndings we suggest that single expo-
ure of MWCNTs upregulates IL-4 and induces pulmonary
brosis. Our hypothesis can further be supported by the
istopathological micrograph displayed in Fig. 9.
ig. 8. Time-dependent changes in the concentration of (A) TNF- and (B) IL-4 in
ifferent days (days 1, 7 and 14) after inhalation. Values are expressed in mean ±
ontrol  group (P < 0.05). #Values are signiﬁcantly different from MWCNTs exposetivity in BALF collected from rats of rats exposed for 4 h and sacriﬁced
xpressed in mean ± S.D.; (n = 6 animals/group). *Values are statistically
3.3. Histopathology studies
The histopathological changes observed in the lung and
lung associated lymph nodes (tracheo-bronchial) of MWC-
NTs treated and the control animals are summarized in
Table 1 and the microphotographs are illustrated in Fig. 9.
Microscopically, the MWCNT exposed lungs at all
sacriﬁce time points have revealed the deposition of
non-phagocytosed MWCNTs as black granular agglomer-
ated masses in airways, alveolar lumen and interstitium
(Fig. 9A–D). The alveolar macrophages with intracytoplas-
mic  MWCNTs which is suggestive of phagocytosis were
observed over bronchiolar epithelial lining (Fig. 9B), pul-
monary interstitial space (Fig. 9A and C) and alveolar
lumen (Fig. 9D) indicating rapid onset and continuum
of pulmonary clearance mechanism. The appearance of
 BALF of rats exposed to MWCNTs for 4 h and sacriﬁced intermittently on
 S.D.; (n = 6 animals/group). *Values are statistically signiﬁcant from the
d rats sacriﬁced on day 1 post-exposure (P < 0.05).
118 A.P. Francis et al. / Toxicology Reports 2 (2015) 111–120
Fig. 9. Histopathological changes observed in the lungs and trachea-bronchial lymph nodes of MWCNT exposed rats. (A) Aggregates of MWCNT (arrow)
in  alveolar duct interstitium. Arrow head indicates the bi-nucleated alveolar macrophage. Note the alveolar wall thickening with proliferating interstitial
ﬁbroblasts. (B) Ciliary escalation of MWCNT laden macrophages (arrow) over bronchiolar epithelium (day 1 post-exposure). (C) Alveolar proteinosis with
occasional multi-nucleated macrophages in alveolar lumen (arrow head). Arrow indicates the deposition of MWCNTs in alveolar interstitium. In addition
the  presence of granular, eosinophilic material (encircled) in the alveolar space (day 7 post-exposure). (D) Focal, moderate alveolar histiocytosis with
prominent cytoplasmic vacuolation and phagocytosed MWCNT (day 7 post-exposure). (E) Chronic inﬂammation of alveoli. Arrow indicates the MWCNT
laden  histiocytes (day 14 post-exposure). (F and G) The presence of translocated MWCNT laden macrophages in trachea-bronchial lymph node at day 7 and
day  14 post-inhalation respectively. (H) Focal to multifocal early stage epitheloid granuloma (arrow) at pulmonary interstitium (day 14 post-exposure). (H
and  E) ×400 (A, C–H), ×100 (B).
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Table  1
Summary of histopathological lesions and pulmonary distribution of MWCNTs observed in the lungs of rat with MWCNTs for 4 h.
Groups Control MWCNT
Day 1 Day 7 Day 14
Total  number of animals 6 6 6 6
No.  of animals examined 6 6 6 6
Free MWCNTs, airways/alveoli 0 6 6 3
MWCNT laden macrophages, alveolar 0 6 6 6
MWCNT laden macrophages, BALT 0 0 3 4
MWCNT laden macrophages, TBLN 0 0 4 6
Histiocytosis, alveolar 0 0 3 4
Proteinosis, alveolar 0 0 2 4
Hyperplasia, lymphoid, BALT 0 0 2 4
Inﬁltrates, mononuclear, perivascular 1 4 6 6
Inﬁltrates, mixed, alveolar/interstitial 1 0 3 6
Inﬂammation, acute, alveolar 1 3 3 0
Inﬂammation, chronic, granulomatousa, epitheloid, alveolar/interstitial 0 0 4 6
Fibrosis, interstitial 0 0 4 5
BALT – bronchus associated lymphoid tissue; TBLN – tracheo-bronchial lymph node.
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i-, multi- and or anucleated alveolar macrophages with or
ithout intracytoplasmic phagocytosed MWCNTs (Fig. 9A
nd C) was observed at all sacriﬁce time points.
Apart from the above microscopic ﬁndings, 3/6 animals
howed acute pulmonary inﬂammation and 4/6 animals
howed diffuse mononuclear inﬂammatory cell inﬁltration
round pulmonary perivascular region on day 1 post-
xposure. On day 7 post-exposure, the translocation of
nhaled MWCNT was observed by the presence of MWCNT
aden macrophages in BALT (intrapulmonary) and tracheo-
ronchial lymph nodes (extrapulmonary) (Fig. 9F and
). The alveolar lumen had minimal to mild amount of
ranular, eosinophilic material (alveolar proteinosis) sug-
estive of ongoing pulmonary epithelial injury (Fig. 9A,
 and H). Alveolar histiocytosis (Fig. 9D) characterized
y the presence of two or more alveolar macrophages
ith enormous, highly vacuolated foamy cytoplasm in
ocal to multifocal areas of alveolar lumen were observed.
ost of these macrophages had intracytoplasmic phago-
ytosed MWCNTs. Inﬁltration of mixed inﬂammatory cells
n alveolar space along with acute pulmonary inﬂamma-
ion was observed. However, some animals showed the
hronic inﬂammatory reactions with the development of
arly stage epitheloid granulomas (Fig. 9H) surrounding the
WCNTs and interstitial ﬁbrosis along with acute inﬂam-
ation on day 7 sacriﬁce time point. These granulomas
ere well organized, discrete, and multifocal and majorly
istributed at centri-acinar regions. However, the appear-
nce of either Langhan’s giant cell or foreign body type giant
ells was not found within the granulomas.
The histopathological changes conﬁrm the biopersis-
ence of MWCNTs, which leads to the chronic inﬂamma-
ion. Macrophages with phagocytosed MWCNT are capable
f inducing granuloma which in turn restricts the mobil-
ty of the nanotubes, thus increasing the biopersistence.
imilar histopathological ﬁndings reported by several
ther workers [9,18,25,33] showed that the inhalation of
WCNTs induces mono and polymorphonuclear inﬂam-
atory cell inﬁltration, impairment of function of alveolar
acrophages, epithelial cell hyperplasia, peribronchiolar.
inﬂammation and microgranulomas in lungs. These reports
support our present ﬁndings.
4. Conclusion
We  have investigated the effect of single exposure
of MWCNT in rats by intermittent sacriﬁce. The effects
were monitored by BALF and histopathological analysis.
We interpret that MWCNT induces inﬂammation, ﬁbrosis
and granuloma characterized by progressive elevation of
TNF alpha and IL-4. Histopathological studies further sup-
port our view and reveal the distribution of MWCNT in
lungs and TBLN. We  conclude that MWCNT-induced pul-
monary toxicity is considerable even on single exposure.
As the occupational and intentional exposure to MWCNT
is increasing now-a-days, we warrant the urgent need to
explore its repeated dose toxicity and validate an appro-
priate antitoxic candidate.
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